HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hillel Laks Abbas Ardehali Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fischbein, M. P. Articles by Ardehali, A. Search for Related Content PubMed PubMed Citation Articles by Fischbein, M. P. Articles by Ardehali, A. Related Collections Transplantation - heart

J Thorac Cardiovasc Surg 2003;126:216-223
© 2003 The American Association for Thoracic Surgery

Cardiothoracic transplantation

Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts

^a Division of Cardiothoracic Surgery, Department of Surgery, University of California at Los Angeles, Los Angeles, Calif, USA
^b Department of Departments of Microbiology, Immunology, and Molecular Genetics,, University of California at Los Angeles, Los Angeles, Calif, USA
^c Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, Calif, USA

Received for publication May 28, 2002. Received for publication July 22, 2002; revisions received September 10, 2002; accepted for publication September 23, 2002.

^* Address for reprints: Abbas Ardehali, MD, Division of Cardiothoracic Surgery, 62-246 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA, USA 90095
aardehali{at}mednet.ucla.edu

OBJECTIVE: Interleukin-10 is a pleiotrophic cytokine with variable effects on the alloimmune response, depending on the experimental model system. The purpose of this study was to determine the role of regulated interleukin-10 expression on the development of chronic rejection in heart transplantation, or cardiac allograft vasculopathy.

METHODS: Donor hearts from B6.C-H2^bm12 mice were transplanted into wild-type and interleukin-10 transgenic recipients. In interleukin-10 transgenic recipients, murine interleukin-10 cytokine is produced under the control of human interleukin-2 promoter. Donor hearts were sacrificed at days 7 and 24. No immunosuppression was used. Intimal proliferation was measured morphometrically. Intragraft cellular infiltrate was defined by both immunohistochemistry and flow cytometry. Intracellular cytokine staining assay was performed to determine both the type and source of intragraft cytokines.

RESULTS: Hearts transplanted into wild-type recipients developed severe cardiac allograft vasculopathy by 24 days. Intimal lesions were absent in the donor hearts transplanted into interleukin-10 transgenic recipients. The number of graft-infiltrating T lymphocytes and the percentage of interleukin-2/interferon- producing T lymphocytes were markedly reduced in interleukin-10 transgenic recipients. Finally, the overexpression of interleukin-10 resulted in the decline of graft-infiltrating macrophages at all time points.

CONCLUSIONS: Regulated expression of interleukin-10 inhibits cardiac allograft vasculopathy development via reduction of mononuclear cell recruitment and alteration of their cytokine profile. This strategy may prove beneficial in controlling the alloimmune response in solid organ transplants.

This article has been cited by other articles:

				A. Schober Chemokines in Vascular Dysfunction and Remodeling Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1950 - 1959. [Abstract] [Full Text] [PDF]

				C. Schmidt-Lucke, A. Aicher, P. Romagnani, B. Gareis, S. Romagnani, A. M. Zeiher, and S. Dimmeler Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2425 - H2431. [Abstract] [Full Text] [PDF]